Mid-dilution: The perfect balance between convection and diffusion

Contributions to Nephrology

Volumn 149, Issue , 2005, Pages 107-114

  Santoro, A ^a,b   Conz, P A ^b   De Cristofaro, V ^c   Acquistapace, I ^c   Gaggi, R ^a   Ferramosca, E ^a   Renaux, J L ^c   Rizzioli, E ^b   Wratten, M L ^c  

^a Cyberonics Inc   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Policlinico SOrsola Malpighi ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION; EQUIPMENT DESIGN; HEMODIAFILTRATION; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; THERMODYNAMICS;

BLOOD; CONVECTION; DIFFUSION; EQUIPMENT DESIGN; HEMODIAFILTRATION; HUMANS;

EID: 20544433449     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000085469     Document Type: Article

References (14)

1. Beerenhout CH, Kooman JP, Luik AJ, Jeuken-Mertens, von der Sands FM, Leunissen KML: Optimizing renal replacement therapy - A case for online filtration therapies? Nephrol Dial Transplant 2002;17:2065-2070.
2. Maduell F, Del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, Calvo C, Torrengrosa I, Navarro V: Change from conventional haemodiafiltration to online haemodiafiltration. Nephrol Dial Transplant 1999;14:1202-1207.
3. Babb A, Ahmad S, Bergstrom J, Scribner BH: The middle molecule hypothesis in perspective. Am J Kidney Dis 1981;1:46-50.
4. Milutinovic J, Babb AL, Eschbach JW, Follette WC, Graefe U, Strand MJ, Scribner BH: Uremic neuropathy: Evidence of middle molecule toxicity. Artif Organs 1978;2:45-51.
5. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Burnet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayer B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-1943.
6. Masakane I: Selection of dilutional method for on-line HDF, pre- or post-dilution. Blood Purif 2004;22:49-54.
7. Leypoldt J: Solute fluxes in different treatment modalities. Nephrol Dial Transplant 2000;15:3-9.
8. Pedrini LA, De Cristofaro V: On-line mixed hemodiafiltration with a feedback for ultrafiltration control: Effect on middle-molecule removal. Kidney Int 2003;64:1505-1513.
9. Krieter D, Falkenhain S, Chalabi L, Collins G, Lemke HD, Canaud B: Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration. Kidney Int 2005;67:349-356.
10. Krieter D, Collins G, Summerton J, Spence E, Moragues HL, Canaud B: Mid-dilution on-line haemodiafiltration in a standard dialyser configuration. Nephrol Dial Transplant 2005;20:155-160.
11. Bergstrom J, Wehle B: No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987;1:628-629.
12. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996;50:1013-1018.
13. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int 1999;55:286-293.
14. Ward R, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000;11:2344-2350.